During an uncertain time, we distil our Brexit considerations into 3 key messages for Marketing Authorisation Holders.
MHRA contact marketing authorisation holders to give further details about the automatic transfer of Centrally…
The UK government releases No-Deal Brexit advice for several topics related to the supply of medicines
EMA advises Orphan Designation holders to transfer to legal entities in the EEA
An update to our appraisal of the impact of Brexit on Regulatory Strategy
EMA reveal that their workload takes a hit due to Brexit and they anticipate a 30% loss in staff